| |
|
|
|
|
|
|
|||
|
Blood, 15 January 2007, Vol. 109, No. 2, pp. 533-542. Prepublished online as a Blood First Edition Paper on September 28, 2006; DOI 10.1182/blood-2006-01-035634.
HEMATOPOIESIS The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration1 Institute of Hematology and Medical Oncology "L. & A. Seràgagnoli," University of Bologna, and Stem Cell Research Center, S. Orsola-Malpighi Hospital, Bologna, Italy; 2 Department of Biomedical Sciences, Section of Biochemistry, University of Modena and Reggio Emilia, Modena, Italy; 3 Division of Hematology-Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy; 4 Department of Experimental and Diagnostic Medicine, Section of General Pathology, and Interdisciplinary Center for the Study of Inflammation (ICSI), University of Ferrara, Italy
Homing and engraftment of hematopoietic stem cells (HSCs) to the bone marrow (BM) involve a complex interplay between chemokines, cytokines, and nonpeptide molecules. Extracellular nucleotides and their cognate P2 receptors are emerging as key factors of inflammation and related chemotactic responses. In this study, we investigated the activity of extracellular adenosine triphosphate (ATP) and uridine triphosphate (UTP) on CXCL12-stimulated CD34+ HSC chemotaxis. In vitro, UTP significantly improved HSC migration, inhibited cell membrane CXCR4 down-regulation by migrating CD34+ cells, and increased cell adhesion to fibronectin. In vivo, preincubation with UTP significantly enhanced the BM homing efficiency of human CD34+ cells in immunodeficient mice. Pertussis toxin blocked CXCL12- and UTP-dependent chemotactic responses, suggesting that G-protein alpha-subunits (G
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||